HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Sasaki Selected Research

diisopropanolnitrosamine

12/2001FHIT alterations in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
9/2001Elevated expression of transforming growth factor betas and the tumor necrosis factor family in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
1/2001Absence of PTEN/MMAC1 gene mutations in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
12/2000Mutations of adenomatous polyposis coli and beta-catenin genes during progression of lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
11/2000Mutations and reduced expression of the transforming growth factor-beta receptor II gene in rat lung adenocarcinomas induced by N-nitrosobis-(2-hydroxypropyl)amine.
10/2000Mutations of the Smad2 and Smad4 genes in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
10/2000Elevated expression of interleukins in lung adenocarcinomas induced by N-Nitrosobis(2-hydroxypropyl)amine in rats.
2/2000Increased expression of cyclooxygenase-2 protein in rat lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine.
2/2000Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Sasaki Research Topics

Disease

41Neoplasms (Cancer)
01/2022 - 01/2000
11Adenocarcinoma
12/2001 - 02/2000
10Stomach Neoplasms (Stomach Cancer)
10/2013 - 01/2000
10Breast Neoplasms (Breast Cancer)
06/2012 - 08/2000
10Infections
12/2007 - 02/2000
10Carcinoma (Carcinomatosis)
10/2006 - 02/2000
9Hepatocellular Carcinoma (Hepatoma)
01/2013 - 03/2000
9Colorectal Neoplasms (Colorectal Cancer)
06/2012 - 02/2000
8Carcinogenesis
06/2012 - 02/2000
7Thrombosis (Thrombus)
01/2002 - 01/2000
6Asthma (Bronchial Asthma)
11/2005 - 01/2000
6Adenocarcinoma of Lung
12/2001 - 10/2000
5Stroke (Strokes)
06/2010 - 05/2000
5Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2006 - 08/2000
5Chronic Hepatitis C
09/2002 - 09/2000
4Inflammation (Inflammations)
09/2017 - 12/2001
4Body Weight (Weight, Body)
08/2013 - 02/2000
4Esophageal Neoplasms (Esophageal Cancer)
01/2008 - 11/2001
4Adenoma (Adenomas)
01/2002 - 02/2000
4Neutropenia
10/2001 - 10/2000
4Neoplasm Metastasis (Metastasis)
10/2001 - 02/2000
4Ischemia
08/2001 - 04/2000
4Hyperplasia
07/2001 - 02/2000
4Colonic Neoplasms (Colon Cancer)
09/2000 - 01/2000
3Nausea
10/2019 - 02/2001
3Wounds and Injuries (Trauma)
08/2014 - 01/2005
3Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
07/2007 - 03/2000
3Fever (Fevers)
05/2006 - 04/2001
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2006 - 02/2000
3Pain (Aches)
01/2005 - 08/2000
3Leukopenia
06/2002 - 02/2001
3Hyperparathyroidism
02/2002 - 01/2002
3Myocardial Infarction
11/2001 - 02/2000
3Shock
05/2001 - 02/2001
3Pulmonary Tuberculosis
05/2001 - 08/2000
3Lymphatic Metastasis
01/2001 - 02/2000
2Lung Diseases (Lung Disease)
06/2018 - 10/2000
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 05/2000
2Renal Insufficiency (Renal Failure)
11/2013 - 01/2009
2Hemorrhage
01/2013 - 06/2006
2Anorectal Malformations
08/2011 - 06/2008
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2010 - 03/2010
2Dental Caries (Decay, Dental)
03/2008 - 06/2000
2Rhinitis
12/2007 - 12/2001
2Angina Pectoris
05/2006 - 02/2000

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
11/2012 - 02/2000
9diisopropanolnitrosamineIBA
12/2001 - 02/2000
8Pharmaceutical PreparationsIBA
06/2012 - 08/2000
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2008 - 09/2000
6InterferonsIBA
03/2005 - 09/2000
5Fluorouracil (Carac)FDA LinkGeneric
07/2009 - 10/2001
5beta CateninIBA
07/2007 - 03/2000
4Indicators and Reagents (Reagents)IBA
06/2015 - 12/2000
4Biomarkers (Surrogate Marker)IBA
08/2014 - 10/2000
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2014 - 05/2001
4EnzymesIBA
06/2012 - 03/2004
4CytokinesIBA
06/2012 - 07/2000
4rho-Associated KinasesIBA
06/2010 - 08/2001
4fasudil (AT 877)IBA
06/2010 - 01/2001
4InterleukinsIBA
07/2009 - 01/2000
4Codon (Codons)IBA
12/2001 - 10/2000
4Monoclonal AntibodiesIBA
11/2001 - 05/2000
4Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
11/2001 - 08/2000
4Choline (Choline Chloride)IBA
01/2001 - 04/2000
3Interleukin-6 (Interleukin 6)IBA
08/2014 - 10/2000
3Adrenal Cortex Hormones (Corticosteroids)IBA
12/2013 - 10/2000
3Cisplatin (Platino)FDA LinkGeneric
10/2013 - 01/2006
3Prostaglandin-E SynthasesIBA
06/2012 - 03/2010
3Prostaglandins EIBA
06/2012 - 12/2005
3Glutamic Acid (Glutamate)FDA Link
06/2010 - 02/2001
3Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
07/2009 - 10/2003
3SteroidsIBA
03/2007 - 06/2001
3Messenger RNA (mRNA)IBA
10/2006 - 04/2001
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2006 - 10/2000
3CollagenIBA
03/2006 - 01/2000
3Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2005 - 05/2000
3CalciumIBA
01/2005 - 05/2001
3Dihydrotachysterol (AT 10)IBA
01/2005 - 09/2001
3Anti-Bacterial Agents (Antibiotics)IBA
10/2001 - 02/2000
3Docetaxel (Taxotere)FDA Link
08/2001 - 07/2000
3RNA (Ribonucleic Acid)IBA
01/2001 - 10/2000
3Biological ProductsIBA
01/2001 - 10/2000
3Transforming Growth Factor beta (TGF-beta)IBA
01/2001 - 10/2000
2MacrolidesIBA
06/2018 - 05/2001
2iodixanol (Visipaque)FDA Link
11/2013 - 08/2013
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
06/2012 - 03/2010
2ProstaglandinsIBA
06/2012 - 12/2005
2Anti-Infective Agents (Microbicides)IBA
06/2012 - 10/2001
2taxaneIBA
06/2012 - 08/2001
2Trastuzumab (Herceptin)FDA Link
11/2009 - 11/2001

Therapy/Procedure

25Therapeutics
10/2019 - 08/2000
17Drug Therapy (Chemotherapy)
10/2019 - 08/2000
3Intravenous Injections
08/2013 - 05/2000
3Intravenous Administration
01/2005 - 08/2001
3Parathyroidectomy
02/2002 - 01/2002
3Thyroidectomy
01/2002 - 06/2001
3Lasers (Laser)
01/2002 - 05/2000
3Renal Dialysis (Hemodialysis)
03/2001 - 01/2000
2Radiotherapy
11/2019 - 10/2001
2Cardiopulmonary Bypass (Heart-Lung Bypass)
06/2006 - 03/2001